IRIS
GALLO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.503
NA - Nord America 2.341
EU - Europa 843
SA - Sud America 278
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 42
OC - Oceania 4
Totale 9.071
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.101
US - Stati Uniti d'America 2.231
CN - Cina 543
IT - Italia 483
BD - Bangladesh 323
HK - Hong Kong 245
BR - Brasile 180
VN - Vietnam 112
FR - Francia 85
GB - Regno Unito 79
DE - Germania 46
CA - Canada 40
MX - Messico 40
IN - India 39
NL - Olanda 31
AR - Argentina 29
ID - Indonesia 22
EC - Ecuador 19
FI - Finlandia 16
ZA - Sudafrica 16
CO - Colombia 15
CZ - Repubblica Ceca 15
PL - Polonia 15
UA - Ucraina 15
TR - Turchia 14
MY - Malesia 12
CL - Cile 10
ES - Italia 10
PH - Filippine 10
PK - Pakistan 10
RU - Federazione Russa 10
SA - Arabia Saudita 10
VE - Venezuela 10
JM - Giamaica 7
CR - Costa Rica 6
JP - Giappone 6
SE - Svezia 6
UY - Uruguay 6
CH - Svizzera 5
HN - Honduras 5
IE - Irlanda 5
IQ - Iraq 5
KE - Kenya 5
PY - Paraguay 5
AT - Austria 4
AZ - Azerbaigian 4
BH - Bahrain 4
BY - Bielorussia 4
KR - Corea 4
LB - Libano 4
NP - Nepal 4
AU - Australia 3
BE - Belgio 3
CY - Cipro 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
JO - Giordania 2
KH - Cambogia 2
MN - Mongolia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BJ - Benin 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GN - Guinea 1
IS - Islanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
ML - Mali 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
SC - Seychelles 1
SO - Somalia 1
SV - El Salvador 1
TL - Timor Orientale 1
Totale 9.006
Salva come PNG Salva come JPEG
Città #
San Jose 479
Ashburn 462
Singapore 373
Rome 268
Hong Kong 236
Hefei 160
Beijing 157
Council Bluffs 98
Columbus 86
Dallas 84
Phoenix 84
Santa Clara 74
Lauterbourg 73
Shanghai 69
Boardman 61
New York 53
Los Angeles 46
Ho Chi Minh City 42
London 38
Mexico City 26
Hanoi 25
Buffalo 24
São Paulo 20
Amsterdam 17
Munich 17
San Francisco 16
Brno 15
Seattle 15
Milan 14
Toronto 13
Turku 12
Warsaw 12
Boston 11
Brasília 11
Naples 11
Orem 11
Atlanta 10
Montreal 10
Bologna 9
Manchester 9
Charlotte 8
Chennai 8
Chicago 8
Haiphong 8
Las Vegas 8
Pune 8
Rio de Janeiro 8
Brooklyn 7
Guangzhou 7
Johannesburg 7
Pasadena 7
Bari 6
Da Nang 6
Denver 6
Guayaquil 6
Verona 6
Washington 6
Brownsville 5
Frankfurt am Main 5
Houston 5
Lahore 5
Miami 5
Tokyo 5
Turin 5
Bogotá 4
Brescia 4
Catania 4
Helsinki 4
Kuala Lumpur 4
Montevideo 4
Nairobi 4
New Delhi 4
Palermo 4
Paris 4
Philadelphia 4
San José 4
Stockholm 4
Acalanes Ridge 3
Baku 3
Barquisimeto 3
Canberra 3
Cape Town 3
City of London 3
Guatemala City 3
Helena 3
Istanbul 3
Kingston 3
Krasnodar 3
Madrid 3
Manama 3
Manaus 3
Medellín 3
Milwaukee 3
Minsk 3
Mumbai 3
Poplar 3
Quito 3
Ribeirão Preto 3
Richmond 3
Riyadh 3
Totale 3.527
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 271
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 263
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 253
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 245
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 243
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 240
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 239
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 230
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 223
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 222
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 222
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 221
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 217
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 212
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 206
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 204
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 182
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 163
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 156
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 147
A challenging alfa-fetoprotein in a cirrhotic patient 139
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 133
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 130
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 122
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 121
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 118
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 118
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 117
ALT levels are associated with metabolic parameters and age in a large real-life population. 117
Pain and Frailty in Hospitalized Older Adults 114
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 109
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 105
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 99
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 98
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 98
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 97
Sarcopenia in Chronic Liver Disease: The Emerging Role of Ultrasound in Determining Muscle Mass, Strength and Clinical Outcomes 96
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 91
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 89
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 88
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 87
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 86
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 84
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 84
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 81
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables 80
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 78
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 78
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 77
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 76
Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study 72
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 71
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 67
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 67
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 64
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 63
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 61
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 60
Steroid-refractory immune related hepatitis may hide viral re-activation 60
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 60
What changed in the Italian internal medicine and geriatric wards during the lockdown 60
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 59
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 57
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 55
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 55
Decoding the molecular and genomic landscape of hepatocellular carcinoma: biomarker discovery, classification frameworks, and therapeutic targeting 53
Renal impairment and anemia during triple therapy 53
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 52
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 50
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study 50
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 49
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 49
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 49
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 46
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 46
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 45
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 42
Editorial: Clinical management of older persons with sarcopenia: current status and future directions 40
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 39
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 36
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 35
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease 26
Beyond fibrosis: the molecular roadmap from MASLD to hepatocellular carcinoma 11
Totale 9.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.948
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202288 0 0 0 0 1 0 2 2 12 0 2 69
2022/202319 0 0 0 0 1 2 5 1 1 3 6 0
2023/2024176 6 14 4 23 13 78 2 6 3 6 5 16
2024/20254.457 38 16 66 12 129 98 77 14 176 263 1.749 1.819
2025/20263.333 243 156 192 300 135 156 779 165 216 289 365 337
2026/2027996 54 292 431 219 0 0 0 0 0 0 0 0
Totale 9.071